Dr. Robert Shorr was the vice president, science & technology, chief scientist at United Therapeutics, Unither; vice president of science & technology at Enzon. He served as associate director of the department of molecular pharmacology at Smithkline. He was co-founder and founder, respectively, of Altira Capital and Consulting LLC, and at Biochem. He is a board member of Brainstorm Cell Therapeutics and served as director of business development for the university’s center for advanced technology in biotechnology established by the State of New York at Suny Stony Brook; chairman of the scientific advisory board at Metabolic Research inc. and trustee at Tissue Engineering Charities, the Imperial College of London. Dr. Shorr also appointed as a member of the scientific advisory board for Vyteris.

slider bt care differently

slider bt discovery

500 characters left
nysehome
videohome
videobutton

Know the Science behind

AEMD Platform
Read More >>
Slide item 1

Another Breakthrough
A phase I Study of the Mitochondrial Metabolism Inhibitor CPI-613 in Combination with High Dose Ara-C and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia

Read More >>
Slide item 2

People behind the Success

Our Team
Read More >>
Slide item 3
announcement1
announcement2
announcement3